Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Despite worldwide outbreak of H1N1 virus, American adults not eager to get vaccinated

American adults are not being vaccinated against the seasonal flu any more often than they were last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus, according to a new RAND Corporation study.

10 Dec 2009

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today released an independent laboratory report indicating that the company's BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against the H1N1 virus.

10 Dec 2009

Patients' urine may provide rapid diagnosis of pneumonia

Doctors may soon be able to quickly and accurately diagnose the cause of pneumonia-like symptoms by examining the chemicals found in a patient's urine, suggests a new study led by UC Davis biochemist Carolyn Slupsky.

10 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

Scientists discover the potential basis for urine test to diagnose CAP

Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.

10 Dec 2009

Nano Mask signs a three year agreement to distribute Wein Products respirators

Nano Mask, Inc. today announced that it has entered into a three year agreement with Wein Products, a manufacturer of disposable respirators, to distribute that company's products as it continues to complete the development of its own proprietary disposable NanoMask respirator and to obtain regulatory approval for the NanoMask.

10 Dec 2009

Washington Post, New York Times examine PEPFAR

The Washington Post examines the Obama administration's goal "to get the 'emergency' out of the President's Emergency Plan for AIDS Relief" and integrate HIV/AIDS programs more into the health infrastructure of recipient countries. A five-year strategy for PEPFAR was released last week.

9 Dec 2009

NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).

9 Dec 2009

Alternative, fast and safe process for producing large quantities of effective flu vaccines

A shortage of flu vaccines may soon become a problem of the past. Researcher Manon Cox has developed an alternative process for producing large quantities of safe and effective vaccines at twice to four times the usual speed. The process is based on using cells in bioreactors instead of fertilised chicken's eggs, which have a limited availability.

9 Dec 2009

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

Hi-Tech Pharmacal Co., Inc. today reported results for the quarter ended October 31, 2009.

9 Dec 2009

VERTICAL Phase II trial results for NHL released

The Takeda Oncology Company today reported data from a clinical trial evaluating a VELCADE based combination for patients with relapsed/refractory non-Hodgkin’s lymphoma (NHL).

9 Dec 2009

Report on the community-acquired pneumonia drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of three blockbuster antibiotics -- levofloxacin, moxifloxacin and piperacillin/tazobactam -- will be the primary factors contributing to a decline of more than 15 percent in the community-acquired pneumonia drug market though 2018.

9 Dec 2009

Research article addresses the relationship between PEG and GER

Gastroesophageal reflux (GER) is a common problem in mechanically ventilated patients and contributes to the development of esophageal mucosal injury and even erosive esophagitis. The relationship between percutaneous endoscopic gastrostomy (PEG) and subsequent development of GER is complex and not well understood.

9 Dec 2009

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells - a process that potentially could be used against a range of chronic viral diseases.

9 Dec 2009

Memgen announces positive clinical data of ISF35 with chemotherapy

Memgen announced today that positive data evaluating its active cellular immunotherapy product, ISF35, in combination with chemotherapy in resistant chronic lymphocytic leukemia (CLL) were presented December 7 during the 51st Annual Meeting of the American Society of Hematology (Abstract #376).

9 Dec 2009

Severe pandemic scenario can impact blood supplies

A German research team has examined data on supply and demand for blood transfusions against a computer simulation of an influenza pandemic, and discovered that a severe pandemic scenario could quickly lead to a deficit of up to 96,000 red blood cell (RBC) transfusion units in Germany alone, creating potentially fatal outcomes. Their study is published today in the journal TRANSFUSION.

9 Dec 2009

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

Celgene International Sàrl announced that investigational data evaluating combination therapy with REVLIMID (lenalidomide) and rituximab in patients with indolent non-Hodgkin’s lymphoma (NHL) were presented during the 51st American Society of Hematology’s annual meeting in New Orleans, LA.

9 Dec 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Despite worldwide outbreak of H1N1 virus, American adults not eager to get vaccinated

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Patients' urine may provide rapid diagnosis of pneumonia

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Scientists discover the potential basis for urine test to diagnose CAP

Nano Mask signs a three year agreement to distribute Wein Products respirators

Washington Post, New York Times examine PEPFAR

NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles

Alternative, fast and safe process for producing large quantities of effective flu vaccines

Hi-Tech Pharmacal reports net sales of $40.9M for the quarter ended October 31, 2009

VERTICAL Phase II trial results for NHL released

Report on the community-acquired pneumonia drug market

Research article addresses the relationship between PEG and GER

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Memgen announces positive clinical data of ISF35 with chemotherapy

Severe pandemic scenario can impact blood supplies

Data evaluating combination therapy with REVLIMID and rituximab in patients with NHL presented

TMZ and small molecule combination appears to lower tumor resistance

Macomb County Health Department opens new H1N1 influenza immunization clinics

Bird influenza viruses have a variety of strategies to cross the species barrier

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in